The Almac Group Celebrates Grand Opening of New North American Headquarters
The Almac Group on Wednesday, May 18 celebrated the official grand opening of its new North American Headquarters in Souderton, PA.
The $120 million, 240,000-square-foot new North American headquarters houses more than 800 employees and has already brought approximately 300 new hires to the greater Philadelphia region. With global headquarters in Craigavon, Northern Ireland, Almac employs more than 3,000 worldwide, with over 1,100 employees based in the US.
Officially opening the building was former US Senator George J. Mitchell, who was Chairman of the historic 1998 Northern Ireland Peace Agreement. Until last week, Mitchell served as President Obama’s Special Envoy to the Middle East. Commenting on the new facility, Mitchell said, “Almac’s Founder Sir Allen McClay had a real vision for this company, and the building we are dedicating today will be a fitting monument to his life and work. This facility will be important not only to the economy of Pennsylvania, but to the health of people all over the world."
In addition to Senator Mitchell, several other dignitaries participated in the grand opening. These include Pennsylvania Department of Community and Economic Development Secretary C. Alan Walker, who attended on behalf of Pennsylvania Governor Tom Corbett, and Almac CEO Alan Armstron.
Lady Heather McClay, wife of the late Sir Allen McClay , dedicated three unique pieces of stained glass commissioned especially for the headquarters. The glass works are interwoven with scientific references, symbols associated with Northern Ireland, as well as images from the official crest of Pennsylvania.
Almac’s new North American headquarters, comprised of a three-story office and administration building, as well as a building for the production, analysis and distribution of clinical trial supplies, was designed by Francis Cauffman Architects of Philadelphia and built by Skanska USA. It strives to maintain sustainability throughout, with low greenhouse gas emissions and a full water reclamation program in place.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
